Establishing the Value of Next-Gen Sequencing

November 22, 2021

Next-generation sequencing (NGS) has been touted by some as the backbone of future precision medicine approaches. This technology could help target treatment to the right patient population, preserving medical resources, reducing hospitalization, and improving patient outcomes. However, there is no agreed-upon method to assess the value of NGS and precision medicine techniques. A forum at the Virtual ISPOR Europe in Milan approached this question from the angles of reimbursement, ecosystem, and public health.

According to Zimmerman et al., “population health outcomes reflect the combined influences of multiple biological and social health determinants, public health efforts and medical care, making “both zip codes and genetic codes” important for health.”